External Funding Opportunities

We invite you to peruse the following list of funding opportunities that may be of interest to injury prevention researchers.  This information is abstracted for brevity; please refer to the sponsor’s website for complete information.

To add other opportunities to this list, please email us.

In addition, we often publicize funding opportunities via our mailing list.  Please become a member to join our mailing list and receive updated information.

• DoD Traumatic Brain Injury and Psychological Health, Focused Program Award (Closing Date for Applications: December 16, 2021)
• DoD Traumatic Brain Injury and Psychological Health, Translational Research Award (Closing Date for Applications: December 16, 2021)
• DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award (Closing Date for Applications: December 16, 2021)
• OVW Fiscal Year 2021 Firearms Technical Assistance Project Pilot Sites Initiative Solicitation (Closing Date for Applications: September 20, 2021)
• Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) (Closing Date for Applications: June 15, 2022)
• Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) (Closing Date for Applications: June 15, 2022)
• Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) (Closing Date for Applications: June 15, 2022)
• Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R21 Clinical Trial Optional) (Closing Date for Applications: October 16, 2021)
• DOD Alcohol and Substance Abuse Disorders Consortium Award (Closing Date for Applications: Sep 08, 2021)
• Notice of Intent to Publish a Funding Opportunity Announcement for the NIH HEAL Initiative: Preventing Opioid Misuse and other Drug Use by Intervening on Social Determinants (R01 Clinical Trials Optional)
• Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 – Clinical Trial Optional) (Expiration Date: May 08, 2024)
• Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional) (Expiration Date: February 19, 2022)
• Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic (Application Due Date: March 15, 2023)
• Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) (Expiration Date: February 06, 2023)
• Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional) (Expiration Date: February 17, 2023)
• Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) (Application Due Dates: February 19, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
• Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (Application Due Dates: February 19, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
• Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) (Application Due Dates: July 19, 2021; November 15, 2021; July 19, 2022; November 15, 2022; July 19, 2023; November 15, 2023 – each letter of intent due 30 days prior)
• Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) (Expiration Date: November 16, 2023)
• State Occupational Safety and Health Surveillance Program (U60) (Expiration Date: September 15, 2022)
• NIOSH Exploratory/Developmental Grant Program (R21) (Expiration Date: November 18, 2023)
• Lizette Peterson-Homer Injury Prevention Grant (Application Due Date: October 15, 2021)
• NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) (Expiration Date: November 16, 2023)
• Notice of Special Interest (NOSI) in Research on Risk and Prevention of Black Youth Suicide (Expiration Date: July 31, 2022)
• Notice of Special Interest (NOSI): Research on Co-morbid Substance Use, Substance Use Disorders, and Other Psychiatric Disorders
• Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) (Expiration Date: August 11, 2022)
• Substance Use/Substance Use Disorder Dissertation Research Award (R36 – Clinical Trials Optional) (Expiration Date: May 08, 2023)
• Advancing Research on SUD through Computational Neuroscience 
• Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults
• Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (Expiration Date: September 08, 2023)
• Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional) (Expiration Date: November 10, 2021)
• Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional) (Expiration Date: November 10, 2021) 
• Innovation at Work (Application due date: February 2022)
• Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) (Expiration Date: November 8, 2022)
• HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) (Expiration Date: September 09, 2022)
• HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 – Clinical Trial Not Allowed) (Expiration Date: September 09, 2022)
• Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) (Expiration Date: September 08, 2021)
• HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 – Clinical Trial Optional) (Expiration Date: September 09, 2021)
• HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 – Clinical Trial Optional) (Expiration Date: September 09, 2021)
• High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) (Expiration Date: September 07, 2021)
• AHRQ Health Services Research Demonstration and Dissemination Grants (R18) (Expiration Date: September 30, 2022)
• AHRQ Small Research Grant Program (R03) (Expiration Date: July 07, 2022)
• AHRQ Health Services Research Projects (R01) (Expiration Date: July 07, 2022)
• Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) (Expiration Date: August 11, 2022)
• Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 – Clinical Trial Optional) (Expiration Date: September 07, 2021)
• Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 – Clinical Trial Optional) (Expiration Date: January 07, 2022)
• Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 – Clinical Trial Optional) (Expiration Date: September 07, 2021)
• Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) (Expiration Date: October 08, 2021)
• Occupational Safety and Health Research (R01) (Expiration Date: November 17, 2023)